These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 36583431)

  • 1. Vessel Patency and Associated Factors of Drug-Coated Balloon for Femoropopliteal Lesion.
    Soga Y; Takahara M; Iida O; Tomoi Y; Kawasaki D; Tanaka A; Yamauchi Y; Tobita K; Kozuki A; Fujihara M; Ando K;
    J Am Heart Assoc; 2023 Jan; 12(1):e025677. PubMed ID: 36583431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-Year Sustained Clinical Efficacy of Drug-Coated Balloon Angioplasty in a Real-World Femoropopliteal Cohort.
    Torsello G; Stavroulakis K; Brodmann M; Micari A; Tepe G; Veroux P; Benko A; Choi D; Vermassen FEG; Jaff MR; Guo J; Dobranszki R; Zeller T;
    J Endovasc Ther; 2020 Oct; 27(5):693-705. PubMed ID: 32583749
    [No Abstract]   [Full Text] [Related]  

  • 3. The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty.
    Scheinert D; Duda S; Zeller T; Krankenberg H; Ricke J; Bosiers M; Tepe G; Naisbitt S; Rosenfield K
    JACC Cardiovasc Interv; 2014 Jan; 7(1):10-9. PubMed ID: 24456716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of non-flow-limiting spiral dissection after drug-coated balloon angioplasty for de novo femoropopliteal lesions.
    Haraguchi T; Kuramitsu S; Tsujimoto M; Kashima Y; Sato K; Fujita T
    Catheter Cardiovasc Interv; 2024 Jan; 103(1):97-105. PubMed ID: 37975201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiographic patterns of restenosis after drug-coated balloon angioplasty for femoropopliteal lesions and 1-year prognosis after repeat endovascular therapy.
    Higashino N; Iida O; Ishihara T; Hata Y; Toyoshima T; Tsukizawa T; Nishian K; Fujihara M; Kawasaki D; Mano T
    Catheter Cardiovasc Interv; 2023 Nov; 102(6):1114-1121. PubMed ID: 37855184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-year clinical outcomes of drug-coated balloon angioplasty and angiographic predictors of restenosis among patients with de novo femoropopliteal lesions.
    Yamaguchi K; Mori S; Fukagawa T; Kishida T; Nakano T; Shirai S; Mizusawa M; Makino K; Honda Y; Tsutsumi M; Kobayashi N; Yamawaki M; Ito Y
    Indian Heart J; 2023; 75(6):403-408. PubMed ID: 37739220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraluminal vs Subintimal Drug-Coated Balloon Angioplasty for the Treatment of Femoropopliteal Chronic Total Occlusions.
    Toyoshima T; Takahara M; Iida O; Tomoi Y; Kawasaki D; Tanaka A; Yamauchi Y; Tobita K; Kozuki A; Fujihara M; Higuchi Y; Soga Y;
    JACC Cardiovasc Interv; 2024 Mar; 17(5):608-618. PubMed ID: 38479962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-Dose vs High-Dose Drug-Coated Balloon for Symptomatic Femoropopliteal Artery Disease: The PROSPECT MONSTER Study Outcomes.
    Nakama T; Takahara M; Iwata Y; Suzuki K; Tobita K; Hayakawa N; Horie K; Mori S; Obunai K; Ohki T;
    JACC Cardiovasc Interv; 2023 Nov; 16(21):2655-2665. PubMed ID: 37804292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A registry-based study of paclitaxel drug-coated balloon angioplasty for the treatment of in-stent restenosis of the femoral-popliteal artery.
    Bertges DJ; Eldrup-Jorgensen J; Chaer RA; Stoner MC; Marone LK; Giles KA; DeRubertis BG; Jacobowitz GR; Cronenwett JL;
    J Vasc Surg; 2024 May; 79(5):1142-1150.e2. PubMed ID: 38190927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Head-to-Head Comparison of 2 Paclitaxel-Coated Balloons for Femoropopliteal Lesions.
    Deloose KR; Lansink W; Brodmann M; Werner M; Keirse K; Gouëffic Y; Verbist J; Maene L; Hendriks JMH; Brunet J; Ducasse E; Levent K; Sauguet A; Vandael F; Vercauteren S; Callaert J
    JACC Cardiovasc Interv; 2023 Dec; 16(23):2900-2914. PubMed ID: 38092496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anemia as a risk factor for restenosis in femoropopliteal arterial disease after drug-coated balloon angioplasty.
    Pan T; Tian SY; Xiong SS; Ji DH; Liu Z; Wang F
    Vascular; 2023 Oct; 31(5):948-953. PubMed ID: 35499107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propensity score-matched analysis of six-month outcomes of paclitaxel-coated balloons combined with UltraScore balloons versus conventional scoring balloons for femoropopliteal lesions.
    Haraguchi T; Tsujimoto M; Otake R; Kashima Y; Sato K; Fujita T
    Diagn Interv Radiol; 2023 May; 29(3):535-541. PubMed ID: 37067068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excimer laser atherectomy combined with drug-coated balloon angioplasty for the treatment of femoropopliteal arteriosclerosis obliterans.
    Su Z; Li Y; Yang S; Guo J; Guo L; Gu Y
    Ann R Coll Surg Engl; 2022 Nov; 104(9):667-672. PubMed ID: 35446161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of Excimer Laser Atherectomy Combined with a Drug-Coated Balloon in De Novo Femoral Popliteal Artery Disease: A Retrospective Study.
    Pan D; Guo J; Su Z; Meng W; Wang C; Guo J; Gu Y
    Ann Vasc Surg; 2024 Feb; 99():26-32. PubMed ID: 37914073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twenty-Four-Month Safety and Effectiveness of TCD-17187 Drug-Coated Balloon for Treatment of Atherosclerotic Lesions in Superficial Femoral and Proximal Popliteal Artery.
    Soga Y; Iida O; Seki SI; Kawasaki D; Anzai H; Ando H; Nakama T; Shinozaki N; Kozuki A; Ishihara M; Urasawa K; Toi S; Tsujita H; Tobita K; Ogata K; Horie K; Hayakawa N; Mori S; Fujihara M; Ohki T; Yuba K; Mano T; Ando K; Nakamura M;
    Cardiovasc Intervent Radiol; 2024 Jun; 47(6):730-740. PubMed ID: 38816504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of mid-outcome among bare metal stent, atherectomy with or without drug-coated balloon angioplasty for femoropopliteal arterial occlusion.
    Yang L; Quan J; Dong J; Ding N; Han Y; Cong L; Lin Y; Liu J
    Sci Rep; 2024 Jan; 14(1):63. PubMed ID: 38167567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeat drug-coated balloon angioplasty for femoropopliteal lesions: 12-month results from a retrospective observational study.
    Haraguchi T; Tsujimoto M; Kashima Y; Sato K; Fujita T
    CVIR Endovasc; 2024 Feb; 7(1):24. PubMed ID: 38421471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective analysis on diameters of drug-coated balloons and predilatation balloons in infra-inguinal endovascular treatment (RABBIT study).
    Iwata Y; Takahara M; Tobita K; Hayakawa N; Mori S; Horie K; Nakama T; Suzuki K; Fukuzawa S
    Cardiovasc Interv Ther; 2024 Jul; 39(3):293-301. PubMed ID: 38632168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing Predictors Influencing Restenosis Following High-Dose Drug-Coated Balloon Angioplasty and Fluoropolymer-Based Drug-Eluting Stenting in Femoropopliteal Artery Lesions.
    Kurata N; Iida O; Takahara M; Asai M; Okamoto S; Ishihara T; Nanto K; Tsujimura T; Hata Y; Toyoshima T; Higashino N; Nakao S; Mano T
    J Endovasc Ther; 2023 Nov; ():15266028231209234. PubMed ID: 37933462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endovascular Therapy with Interwoven Nitinol Stent Placement after Predilation for Heavily Calcified Femoropopliteal Artery Disease: Results of the BURDOCK Study.
    Fujihara M; Takahara M; Iida O; Kawasaki D; Soga Y; Tobita K; Horie K; Takagi T; Okamoto S; Nakama T; Sasaki S; Tsubakimoto Y; Suematsu N
    J Vasc Interv Radiol; 2023 Nov; 34(11):1929-1937. PubMed ID: 37527768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.